Alex Miras is currently a Senior Clinical Lecturer and Consultant in Endocrinology at Imperial College London and interested in the mechanisms through which lifestyle interventions, pharmacotherapy, bariatric surgery and medical devices improve weight, metabolic control and diabetes-related microvascular complications.
et al., 2021, Simple tool to prioritize access to bariatric surgery for people living with obesity during the COVID-19 pandemic, British Journal of Surgery, ISSN:0007-1323
et al., 2021, Roux-en-Y Gastric Bypass Increases Glycemic Variability and Time in Hypoglycemia in Patients With Obesity and Prediabetes or Type 2 Diabetes: A Prospective Cohort Study, Diabetes Care, Vol:44, ISSN:0149-5992, Pages:614-617
et al., 2021, The effect of standard versus longer intestinal bypass on GLP-1 regulation and glucose metabolism in patients with type 2 diabetes undergoing roux-en-Y gastric bypass. The long-limb study, Diabetes Care, Vol:44, ISSN:0149-5992, Pages:1-9
et al., 2021, Long limb compared with standard limb Roux-en-Y gastric bypass for type 2 diabetes and obesity: the LONG LIMB RCT, Efficacy and Mechanism Evaluation, Vol:8, ISSN:2050-4365, Pages:1-54
Miras AD, le Roux CW, 2021, Metabolic surgery versus conventional therapy in type 2 diabetes, The Lancet, Vol:397, ISSN:0140-6736, Pages:256-257